Open the mobile version, with barcode scanning
Class I Ongoing

DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical…

Why: Presence of Particulate matter: Particulate matter identified as glass.

Company
SUN PHARMACEUTICAL INDUSTRIES INC
Princeton, NJ, United States
Reported
Jun 17, 2026
Recall started
May 12, 2026
Where sold
U.S. Nationwide
Amount
675 vials
Full product description
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.
Lots / codes affected
Lot HAG2581B, expires: 05/31/2027

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.